Established
Semaglutide
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Studiedata per legemiddel, med data om seponering som markedsføring ofte utelater.
Established
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Established
Dual GIP / GLP-1 receptor agonist. Mounjaro, Zepbound
Established
GLP-1 receptor agonist. Victoza, Saxenda
Established
GLP-1 receptor agonist. Trulicity
Promising
GLP-1 receptor agonist, oral. Rybelsus
Popular but weak
Unapproved compounded preparation. Various, unbranded
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep, circadian rhythm and the wearables that claim to measure both.
Denne siden ble oversatt automatisk fra engelsk. Henvisningene og tallene er uendret. Les den engelske originalen hvis noe virker merkelig. Les den engelske originalen